Literature DB >> 33730459

The AMP Trials - A Glass Half Full.

Bruce D Walker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33730459     DOI： 10.1056/NEJMe2101131

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity.

Authors:  Jyoti Sutar; Suprit Deshpande; Ranajoy Mullick; Nitin Hingankar; Vainav Patel; Jayanta Bhattacharya
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

2.  Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.

Authors:  Elizabeth J McFarland; Coleen K Cunningham; Petronella Muresan; Edmund V Capparelli; Charlotte Perlowski; Patricia Morgan; Betsy Smith; Rohan Hazra; Lynette Purdue; Paul A Harding; Gerhard Theron; Hilda Mujuru; Allison Agwu; Murli Purswani; Mobeen H Rathore; Britta Flach; Alison Taylor; Bob C Lin; Adrian B McDermott; John R Mascola; Barney S Graham
Journal:  J Infect Dis       Date:  2021-12-01       Impact factor: 7.759

Review 3.  Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.

Authors:  Wilton B Williams; Kevin Wiehe; Kevin O Saunders; Barton F Haynes
Journal:  J Int AIDS Soc       Date:  2021-11       Impact factor: 5.396

4.  Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.

Authors:  Sharana Mahomed; Nigel Garrett; Edmund V Capparelli; Farzana Osman; Ishana Harkoo; Nonhlanhla Yende-Zuma; Tanuja N Gengiah; Derseree Archary; Natasha Samsunder; Cheryl Baxter; Nonhlanhla N Mkhize; Tandile Modise; Kevin Carlton; Adrian McDermott; Penny L Moore; Quarraisha Abdool Karim; Dan H Barouch; Patricia E Fast; John R Mascola; Julie E Ledgerwood; Lynn Morris; Salim S Abdool Karim
Journal:  J Infect Dis       Date:  2022-08-26       Impact factor: 7.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.